Circulogene Theranostics announced it raised $2.59 Million in an amended filing from an offering of $5 Million
Circulogene Theranostics announced it raised $2.59 Million in an amended filing from an offering of $5 Million
09/01/22, 4:25 PM
Location
birmingham
Money raised
$2.59 million
Industry
healthcare
Round Type
seed
Company Info
Location
3125 independence drive
birmingham, alabama, united states
Additional Info
Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics scientists. Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. One tube, one week, complete results. Somatic + Germline; Blood + Tissue + Buccal; DNA + RNA + MSI + PD-L1.
CONTACT
info@circulogene.com
For Asia Pacific inquiries,
please email AsiaPacfic@circulogene.com
For Middle Eastern inquiries,
please email Irem.Agin@circulogene.com.tr